Tu Salud News Update
FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Weight-loss drug Wegovy (semaglutide) is now approved for cardiovascular risk reduction.
NIH Opens Long COVID Trials To Evaluate Treatments For Autonomic Nervous System Dysfunction
Part of the RECOVER Initiative, these trials will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
CDC Study Shows Effectiveness of RSV Immunization for Infants
Early data from the New Vaccine Surveillance Network show nirsevimab is 90% effective in preventing infant hospitalization with RSV.
NIH Scientists Find Weak Points on Epstein-Barr Virus
New details of EBV protein could aid treatment, prevention efforts.
Healthy Recipe: Potato, Leek & Gruyere Pizza
If you think that potatoes and pizza don’t go together, think again.
#HealthEquity
Get the latest updates.
Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@tusaludmag.com. Please remember to add update@tusaludmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2024 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.